(Q44732670)

5 December 2017

title

Lamotrigine as first-line drug in childhood absence epilepsy: a clinical and neurophysiological study (English)

1 reference

childhood absence epilepsy

5 December 2017

1 reference

1 reference

1 reference

Giangennaro Coppola

1

1 reference

5 December 2017

Felicia Licciardi

2

1 reference

5 December 2017

Nicola Sciscio

3

1 reference

5 December 2017

Francesco Russo

4

1 reference

5 December 2017

Marco Carotenuto

5

1 reference

5 December 2017

Antonio Pascotto

6

1 reference

5 December 2017

publication date

1 January 2004

1 reference

5 December 2017

published in

Brain and Development

1 reference

5 December 2017

volume

26

1 reference

5 December 2017

issue

1

1 reference

5 December 2017

page(s)

26-29

1 reference

Lamotrigine in treatment of 120 children with epilepsy

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2803%2900090-1

7 January 2021

The efficacy of lamotrigine on seizure control in 34 children, adolescents and young adults with intellectual and physical disability

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2803%2900090-1

7 January 2021

Lamotrigine in absence and primary generalized epilepsies

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2803%2900090-1

7 January 2021

Lamictal (lamotrigine) monotherapy for typical absence seizures in children

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2803%2900090-1

7 January 2021

Proposal for revised clinical and electroencephalographic classification of epileptic seizures. From the Commission on Classification and Terminology of the International League Against Epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2803%2900090-1

7 January 2021

Lamotrigine in typical absence epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2803%2900090-1

7 January 2021

Lamotrigine as add-on drug in children and adolescents with refractory epilepsy and mental delay: an open trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2803%2900090-1

7 January 2021

Lamotrigine monotherapy in children

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2803%2900090-1

7 January 2021

Pancreatitis associated with valproic acid: a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2803%2900090-1

7 January 2021

Side effects of valproate

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2803%2900090-1

7 January 2021

Altered cognitive functioning in children with idiopathic epilepsy receiving valproate monotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2803%2900090-1

7 January 2021

10.1016/S0387-7604(03)00090-1

Identifiers

DOI

1 reference

5 December 2017

1 reference